Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.

PURPOSE:The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination b...

Full description

Bibliographic Details
Main Authors: Regine Kluge, Lidia Chavdarova, Martha Hoffmann, Carsten Kobe, Bogdan Malkowski, Françoise Montravers, Lars Kurch, Thomas Georgi, Markus Dietlein, W Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Lorrain Wilson, Eva Bergstraesser, Osama Sabri, Christine Mauz-Körholz, Dieter Körholz, Dirk Hasenclever
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4786307?pdf=render
_version_ 1818152692547059712
author Regine Kluge
Lidia Chavdarova
Martha Hoffmann
Carsten Kobe
Bogdan Malkowski
Françoise Montravers
Lars Kurch
Thomas Georgi
Markus Dietlein
W Hamish Wallace
Jonas Karlen
Ana Fernández-Teijeiro
Michaela Cepelova
Lorrain Wilson
Eva Bergstraesser
Osama Sabri
Christine Mauz-Körholz
Dieter Körholz
Dirk Hasenclever
author_facet Regine Kluge
Lidia Chavdarova
Martha Hoffmann
Carsten Kobe
Bogdan Malkowski
Françoise Montravers
Lars Kurch
Thomas Georgi
Markus Dietlein
W Hamish Wallace
Jonas Karlen
Ana Fernández-Teijeiro
Michaela Cepelova
Lorrain Wilson
Eva Bergstraesser
Osama Sabri
Christine Mauz-Körholz
Dieter Körholz
Dirk Hasenclever
author_sort Regine Kluge
collection DOAJ
description PURPOSE:The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS:Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS:The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION:Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making.
first_indexed 2024-12-11T13:58:46Z
format Article
id doaj.art-54031301ed1e42bb8c35755bdd381c69
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T13:58:46Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-54031301ed1e42bb8c35755bdd381c692022-12-22T01:03:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e014907210.1371/journal.pone.0149072Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.Regine KlugeLidia ChavdarovaMartha HoffmannCarsten KobeBogdan MalkowskiFrançoise MontraversLars KurchThomas GeorgiMarkus DietleinW Hamish WallaceJonas KarlenAna Fernández-TeijeiroMichaela CepelovaLorrain WilsonEva BergstraesserOsama SabriChristine Mauz-KörholzDieter KörholzDirk HasencleverPURPOSE:The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS:Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS:The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION:Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making.http://europepmc.org/articles/PMC4786307?pdf=render
spellingShingle Regine Kluge
Lidia Chavdarova
Martha Hoffmann
Carsten Kobe
Bogdan Malkowski
Françoise Montravers
Lars Kurch
Thomas Georgi
Markus Dietlein
W Hamish Wallace
Jonas Karlen
Ana Fernández-Teijeiro
Michaela Cepelova
Lorrain Wilson
Eva Bergstraesser
Osama Sabri
Christine Mauz-Körholz
Dieter Körholz
Dirk Hasenclever
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
PLoS ONE
title Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
title_full Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
title_fullStr Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
title_full_unstemmed Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
title_short Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
title_sort inter reader reliability of early fdg pet ct response assessment using the deauville scale after 2 cycles of intensive chemotherapy oepa in hodgkin s lymphoma
url http://europepmc.org/articles/PMC4786307?pdf=render
work_keys_str_mv AT reginekluge interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT lidiachavdarova interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT marthahoffmann interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT carstenkobe interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT bogdanmalkowski interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT francoisemontravers interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT larskurch interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT thomasgeorgi interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT markusdietlein interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT whamishwallace interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT jonaskarlen interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT anafernandezteijeiro interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT michaelacepelova interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT lorrainwilson interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT evabergstraesser interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT osamasabri interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT christinemauzkorholz interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT dieterkorholz interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT dirkhasenclever interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma